Editas Medicine (EDIT) Return on Capital Employed (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 247.00 |
| Jun 30, 2025 | -2,676.00 |
| Mar 31, 2025 | -1,584.00 |
| Dec 31, 2024 | -1,708.00 |
| Sep 30, 2024 | -1,754.00 |
| Jun 30, 2024 | -1,705.00 |
| Mar 31, 2024 | -736.00 |
| Dec 31, 2023 | 634.00 |
| Sep 30, 2023 | 326.00 |
| Jun 30, 2023 | 418.00 |
| Mar 31, 2023 | -350.00 |
| Dec 31, 2022 | -911.00 |
| Sep 30, 2022 | -688.00 |
| Jun 30, 2022 | -239.00 |
| Mar 31, 2022 | -77.00 |
| Dec 31, 2021 | 202.00 |
| Sep 30, 2021 | -762.00 |
| Jun 30, 2021 | -40.00 |
| Mar 31, 2021 | 191.00 |
| Dec 31, 2020 | -664.00 |
| Sep 30, 2020 | 1,186.00 |
| Jun 30, 2020 | 648.00 |
| Mar 31, 2020 | -28.00 |
| Dec 31, 2019 | 596.00 |
| Sep 30, 2019 | -582.00 |
| Jun 30, 2019 | -554.00 |
| Mar 31, 2019 | -73.00 |
| Dec 31, 2018 | 44.00 |
| Sep 30, 2018 | 177.00 |
| Jun 30, 2018 | -94.00 |
| Sep 30, 2017 | -267.00 |
| Jun 30, 2017 | 693.00 |
| Mar 31, 2017 | 597.00 |
| Dec 31, 2016 | -1,757.00 |
| Sep 30, 2016 | -629.00 |
| Jun 30, 2016 | 129.00 |